ASCEND BY NTHRYS
Research Abroad Products

Molecular Pharmacology Project Topics

Browse all focused areas across all project categories under this field.

Showing 133–144 of 200 project topics
Pharmacokinetics Metabolism Prediction Engine for Lead Optimization
A computational platform that predicts ADMET properties, metabolic pathways, and bioavailability profiles before synthesis, enabling rational drug design. This reduces failed candidates in clinical development and saves $50M+ per drug by eliminating poor PK profiles early in discovery.
Molecular Pharmacology Investment Analytics Click to view more details →
Real-Time Molecular Activity Screening and Data Integration Suite
A cloud-based platform that aggregates, normalizes, and analyzes high-throughput screening data from multiple assay formats with automated quality control. It provides actionable compound rankings and structure-activity relationships in real time, enabling 3-5x faster decision-making for research teams.
Molecular Pharmacology Investment Analytics Click to view more details →
Receptor Occupancy and Target Engagement Modeling Software
An advanced modeling platform that quantifies receptor occupancy dynamics, binding kinetics, and target engagement at the molecular level for drug candidates. It predicts efficacy windows and dosing requirements, enabling dose optimization and reducing Phase II attrition rates by 25-35%.
Molecular Pharmacology Investment Analytics Click to view more details →
Molecular Docking and Virtual Screening Automation Platform
A high-performance computing platform that conducts millions of virtual molecular docking simulations against protein structures with AI-accelerated scoring. It identifies lead compounds in weeks instead of months, reducing upfront synthesis costs and enabling portfolio prioritization across 100+ candidates.
Molecular Pharmacology Investment Analytics Click to view more details →
Drug-Drug Interaction Prediction and Safety Analytics Service
A SaaS service that predicts drug-drug interactions, CYP enzyme interactions, and safety liabilities using proprietary molecular interaction models. This enables faster regulatory submissions, reduces clinical trial failures, and creates new licensing opportunities worth $10M+ per approval.
Molecular Pharmacology Investment Analytics Click to view more details →
Molecular Selectivity and Off-Target Profiling Intelligence Platform
An integrated platform that predicts off-target binding across the entire human proteome and quantifies molecular selectivity profiles for candidate compounds. It identifies safety risks early and de-risks development programs, reducing Phase III failures and saving $100M+ in failed development costs.
Molecular Pharmacology Investment Analytics Click to view more details →
Molecular Property Space Optimization and Lead Series Management Tool
A software solution that maps compound chemical space, predicts patentability windows, and optimizes molecular properties against multiple constraints simultaneously. It accelerates lead series maturation by 50% and maximizes IP portfolio value through intelligent chemical design recommendations.
Molecular Pharmacology Investment Analytics Click to view more details →
Regulatory Compliance Molecular Characterization and Submission Analytics
A specialized platform that automates molecular characterization documentation, predicts regulatory requirements, and generates submission-ready pharmacology packages. It reduces regulatory approval timelines by 6-12 months and streamlines communication with FDA/EMA, accelerating market entry and revenue generation.
Molecular Pharmacology Investment Analytics Click to view more details →
Kinase Selectivity Profiling SaaS Platform
A cloud-based platform that screens compound libraries against 400+ kinase targets to generate comprehensive selectivity profiles in weeks rather than months. Enables pharma companies to de-risk lead optimization and accelerate IND-enabling studies by identifying off-target liabilities early.
Kinase Molecular Pharmacology Selectivity Tools Click to view more details →
AI-Powered Kinase Binding Mode Prediction Engine
Machine learning software that predicts binding modes and selectivity outcomes for novel kinase inhibitors before synthesis using structural and sequence data. Reduces compound design cycles by 40% and improves first-pass selectivity success rates for medicinal chemistry teams.
Kinase Molecular Pharmacology Selectivity Tools Click to view more details →
High-Throughput Kinase Activity Assay Kits
Commercial assay reagent kits and protocols optimized for 384-well and 1536-well formats targeting kinase families with built-in positive controls and hit confirmation workflows. Generates recurring revenue through consumable sales while reducing screening timelines from 6 months to 4 weeks.
Kinase Molecular Pharmacology Selectivity Tools Click to view more details →
Kinase Selectivity Data Analytics Dashboard
Real-time data management and visualization tool that aggregates selectivity screening results across internal programs and public databases for comparative analysis. Delivers competitive intelligence and pattern recognition to inform go/no-go decisions and portfolio strategy.
Kinase Molecular Pharmacology Selectivity Tools Click to view more details →